TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions

Michael D. Gallagher, Eunran Suh, Murray Grossman, Lauren Elman, Leo McCluskey, John C. Van Swieten, Safa Al-Sarraj, Manuela Neumann, Ellen Gelpi, Bernardino Ghetti, Jonathan D. Rohrer, Glenda Halliday, Christine Van Broeckhoven, Danielle Seilhean, Pamela J. Shaw, Matthew P. Frosch, Irina Alafuzoff, Anna Antonell, Nenad Bogdanovic, William BrooksNigel J. Cairns, Johnathan Cooper-Knock, Carl Cotman, Patrick Cras, Marc Cruts, Peter P. De Deyn, Charles Decarli, Carol Dobson-Stone, Sebastiaan Engelborghs, Nick Fox, Douglas Galasko, Marla Gearing, Ilse Gijselinck, Jordan Grafman, Päivi Hartikainen, Kimmo J. Hatanpaa, J. Robin Highley, John Hodges, Christine Hulette, Paul G. Ince, Lee Way Jin, Janine Kirby, Julia Kofler, Jillian Kril, John B.J. Kwok, Allan Levey, Andrew Lieberman, Albert Llado, Jean Jacques Martin, Eliezer Masliah, Christopher J. McDermott, Ann McKee, Catriona McLean, Simon Mead, Carol A. Miller, Josh Miller, David G. Munoz, Jill Murrell, Henry Paulson, Olivier Piguet, Martin Rossor, Raquel Sanchez-Valle, Mary Sano, Julie Schneider, Lisa C. Silbert, Salvatore Spina, Julie Van Der Zee, Tim Van Langenhove, Jason Warren, Stephen B. Wharton, Charles L. White, Randall L. Woltjer, John Q. Trojanowski, Virginia M.Y. Lee, Vivianna Van Deerlin, Alice S. Chen-Plotkin

Research output: Contribution to journal › Article › peer-review

102 Scopus citations

Fingerprint

Dive into the research topics of 'TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions'. Together they form a unique fingerprint.

Medicine & Life Sciences